Price
855.15
+0.86%52W Range
Market Cap
₹8,239.74 Cr
Traded: ₹14.66 Cr (0.18%) 0.0x
Free Float: ₹2,191.77 Cr (0.67% of FF traded)
Volume · 60D trend
1.72 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | +41.0% | +36.0% | -- | +44.0% | Stable |
| ROE | +14.0% | +14.0% | +12.0% | -- | -- | Stable |
| Return | -- | -- | +40.0% | +27.0% | -- | Decelerating |
| Profit | -- | +57.0% | +39.0% | -- | +27.0% | Decelerating |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 393 | 342 | 320 | 279 | 258 | 232 | 219 | 218 | 212 | 178 | 167 | 171 | 155 | 144 | 138 | 128 |
| Expenses | 301 | 262 | 246 | 215 | 193 | 175 | 164 | 163 | 158 | 131 | 120 | 126 | 113 | 105 | 101 | 94 |
| Operating Profit | 92 | 80 | 74 | 65 | 64 | 57 | 55 | 55 | 54 | 47 | 46 | 46 | 41 | 38 | 36 | 34 |
| OPM % | 23.0% | 23.0% | 23.0% | 23.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 26.0% | 28.0% | 27.0% | 27.0% | 27.0% | 26.0% | 26.0% |
| Other Income | 4 | 7 | 8 | 9 | 9 | 5 | 4 | 3 | 4 | 6 | 5 | 4 | 1 | 1 | 1 | 1 |
| Interest | 7 | 5 | 1 | 0 | 0 | 1 | 2 | 2 | 3 | 0 | 0 | 3 | 6 | 6 | 6 | 5 |
| Depreciation | 28 | 30 | 24 | 19 | 15 | 13 | 17 | 16 | 11 | 8 | 8 | 7 | 7 | 8 | 7 | 6 |
| Profit Before Tax | 61 | 52 | 57 | 55 | 59 | 49 | 40 | 40 | 43 | 44 | 44 | 40 | 29 | 25 | 24 | 23 |
| Tax % | 26.0% | 14.0% | 25.0% | 25.0% | 28.0% | 20.0% | 24.0% | 23.0% | 29.0% | 13.0% | 33.0% | 30.0% | 35.0% | 31.0% | 12.0% | 30.0% |
| Net Profit | 45 | 45 | 43 | 41 | 42 | 39 | 30 | 31 | 30 | 38 | 29 | 28 | 19 | 17 | 21 | 16 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 4.9 | 4.9 | 4.7 | 4.3 | 4.4 | 4.0 | 3.2 | 3.6 | 3.5 | 4.5 | 3.4 | 3.2 | 2.9 | 2.6 | 3.2 | 2.5 |
| Sales Growth (YoY) | -- | 47.4% | 46.2% | 28.3% | 21.7% | 30.4% | 31.4% | 27.1% | 37.1% | 23.6% | 21.3% | 33.9% | 39.1% | -- | -- | -- |
| Sales Growth (QoQ) | -- | 6.9% | 14.7% | 8.1% | 11.2% | 5.9% | 0.5% | 2.8% | 19.1% | 6.6% | -2.3% | 10.3% | 7.6% | 4.3% | 7.8% | -- |
| OP Growth (YoY) | 43.8% | 40.4% | 34.5% | 18.2% | 18.5% | 21.3% | 19.6% | 19.6% | 31.7% | 23.7% | 27.8% | 35.3% | -- | -- | -- | -- |
| OP Growth (QoQ) | 15.0% | 8.1% | 13.8% | 1.6% | 12.3% | 3.6% | 0.0% | 1.9% | 14.9% | 2.2% | 0.0% | 12.2% | 7.9% | 5.6% | 5.9% | -- |
| Profit Growth (YoY) | -- | 22.7% | 48.7% | 33.3% | 38.4% | 1.0% | 3.4% | 12.1% | 59.6% | 121.4% | 38.8% | 70.4% | 73.1% | -- | -- | -- |
| EPS Growth (YoY) | -- | 22.6% | 49.0% | 18.6% | 23.2% | -10.1% | -8.1% | 12.5% | 21.6% | 69.3% | 6.2% | 30.0% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | 4.7% | 10.1% | -1.8% | 8.5% | 27.2% | -12.5% | 2.0% | -20.8% | 29.9% | 7.2% | 10.3% | 10.2% | -18.5% | 31.2% | -- |
| OP Margin | -- | 23.4% | 23.1% | 23.3% | 24.8% | 24.6% | 25.1% | 25.2% | 25.5% | 26.4% | 27.5% | 26.9% | 26.4% | 26.4% | 26.1% | 26.6% |
| Net Margin | -- | 13.2% | 13.4% | 14.7% | 16.3% | 16.8% | 13.7% | 14.2% | 14.2% | 21.4% | 17.4% | 16.4% | 12.3% | 11.8% | 15.2% | 12.5% |
| Material Cost % | -- | 18.2% | 19.5% | 20.2% | 20.8% | 20.1% | 19.2% | 19.8% | 22.1% | 21.1% | 18.9% | 21.1% | 18.1% | 17.9% | 16.6% | 18.1% |
| Employee Cost % | -- | 20.5% | 19.8% | 19.3% | 18.7% | 18.9% | 19.4% | 19.0% | 16.3% | 17.9% | 17.9% | 16.6% | 17.4% | 17.4% | 17.2% | 18.6% |
| P/S | 6.18 | 7.22 | 7.63 | 6.92 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 45.49 | 49.17 | 49.63 | 44.85 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 4.63 | 4.87 | 4.92 | 4.05 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50We hereby submit Newspaper Advertisement for information regarding the 19th Annual General Meeting of the Company.
We hereby submit Intimation of the date of 19th Annual General Meeting of the Company.
We hereby submit Earnings Call Transcript Q1FY27.
We hereby submit Monitoring Agency Report for the quarter ended June 30, 2026 (IPO).
We hereby submit Earnings Call Recording for Q1FY27.
We hereby submit Newspaper Publication of Unaudited Financial Results - Q1FY27.
We hereby submit revised Investor Presentation for Q1FY27.
We hereby submit intimation regarding Schedule of Investor Meet.
We hereby submit intimation regarding approval of ESOP Scheme 2026.
We hereby submit intimation regarding fixation of the Record Date for the purpose of Interim Dividend.
We hereby submit intimation regarding Declaration of Interim Dividend.
We hereby submit Investor Presentation for Q1FY27.
We hereby submit Press Release for Q1FY27.
We hereby submit Unaudited Financial Results for the Q1FY27.
We hereby submit Unaudited Financial Results for Q1FY27, Interim Dividend, ESOP Scheme 2026, etc.
We hereby submit intimation regarding Grant of ESOP under Yatharth Hospital & Trauma Care Services Employee Stock Option Scheme- 2024.
We hereby submit intimation regarding Schedule of Investor Conference.
We hereby submit Schedule of Earnings Conference Call Q1 FY27.
Yatharth Hospital & Trauma Care Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve the ....
We hereby submit Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 for Q1 FY27.
We hereby submit intimation regarding Schedule of Investors Visit.
We hereby submit intimation regarding the Closure of Trading Window for Q1 FY27.
We hereby submit intimation regarding update on hospital asset acquisition in sector 40, Gurugram
We hereby submit intimation regarding Schedule of Investor Conference.
We hereby submit intimation regarding Schedule of Investor Conference.
We hereby submit Earnings Call Recording for Q4FY26
We hereby submit intimation regarding Schedule of Conference Call.
We hereby submit Newspaper Publication of Financial Results - Q4 & FY26.
We hereby submit Investor Presentation for Q4 & FY26.
We hereby submit Audited Financial Results Q4 and FY2026
We hereby submit Press Release for Q4 and FY2026.
We hereby submit Audited Financial Results for Q4 and FY2026
We hereby submit Schedule of Earnings Conference Call Q4 FY 26.
Yatharth Hospital & Trauma Care Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve Audited ....
We hereby submit Monitoring Agency Report for the quarter ended March 31, 2026 - QIP.
We hereby submit Monitoring Agency Report for the quarter ended March 31, 2026 - IPO.
We hereby submit the Voting Results of Postal Ballot of the Company held on May 12, 2026.
We hereby submit the Outcome of Postal Ballot of the Company held on May 12, 2026.
We hereby submit the Scrutinizer Report of Postal Ballot of the Company held on May 12, 2026.
We hereby submit intimation regarding Hospital Asset Acquisition in Sector 40 Gurugram.
We hereby submit Press Release on Hospital Asset Acquisition in Sector 40 Gurugram.
We hereby submit intimation regarding Hospital Asset Acquisition in Sector 40 Gurugram.
We hereby submit Annual Secretarial Compliance Report for financial year ended March 31, 2026.
We hereby submit Newspaper Publication for Notice of Postal Ballot and E-voting Information.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
We hereby submit Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 for Q4 FY26.
We hereby submit Postal Ballot Notice - Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulation, 2015.
We hereby submit intimation regarding the Closure of Trading Window for Q4 FY26.
We hereby submit intimation regarding Schedule of Investors Meet.
We hereby submit intimation regarding Schedule of Investors Visit.
Credit Ratings
6Concalls
14Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025Jun 2025
30 Jun 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Nov 2023
30 Nov 2023Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023Held by ETFs
3 ETFs hold yatharth · sorted by weight
Held by Mutual Funds
13 schemes hold yatharth · sorted by weight